跳至主要内容
临床试验/NCT02458976
NCT02458976Unknown不适用

Pulsed-dye Laser Treatment Prior to Surgical Excision

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
Scar appearance

研究概览

简要总结

This prospective pilot study will investigate whether use of a pulsed dye laser (PDL) prior to surgical excision can improve the appearance and symptoms of scars. The primary outcome measurement for the study is the quality of the scar in areas pre-treated with PDL vs. control (cryogen spray only). For this study, subjects who are scheduled for a dermatologic surgical excision will have half of the surgical area pre-treated with PDL and the other half pre-treated with cryogen spray.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with ages between 18 and 65 years, who are scheduled for a dermatologic surgical excision
  • Subjects requiring surgical excisions for any condition
  • Subjects with any Fitzpatrick skin type
  • Willingness to participate in the study
  • Willingness to receive experimental treatment
  • Informed consent agreement signed by the subject
  • Willingness to follow the follow-up schedule
  • Willingness to not use any other scar treatments during the study period (i.e scar massage, over-the-counter silicone pads, intralesional steroid of 5-fluorouracil injections, laser treatments)

排除标准

  • Pregnancy
  • Prior scar in area to be treated
  • Known photoallergy to visible light (i.e polymorphous light eruption)
  • Subject is unable to comply with treatment or follow-up visits
  • Subject with a history of being on photosensitive medications for the past 3 months (thiazides [used to treat high blood pressure], tetracyclines, fluoroquinolones griseofulvin or sulfonamides [used to treat infections], sulfonylureas [used to treat diabetes], calcium channel blockers [used to treat hypertension], phenothiazines [used to treat serious emotional problems]).
  • Known autoimmune disease (some autoimmune diseases can lead to sensitivity to light, such as lupus erythematosus)
  • Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device

结局指标

主要结局

Scar appearance

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Rox Anderson, MD

Professor of Dermatology

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

Pulsed-dye Laser Treatment Prior to Surgical Excision | 临床试验